nivolumab
bms
['nivo', 'congrat', 'nivolumab']
one of the highlights of for me. exciting data exploring lower doses of nivolumab in hn cancer. there is a need to explore lower doses of io globally for $$ and tolerability. congratulations and group! #medtwitter #asco22 
Physician | IM- @UMassChan @baystateIM l PGY-5 Hem/Onc- UT Houston l Chief Fellow 22-23| Interests: SCD, thoracic oncology, clinical education| Tweets are mine